181 related articles for article (PubMed ID: 21119195)
81. Sildenafil: a definitive NO in COPD.
Vonk-Noordegraaf A; Boerrigter BG
Eur Respir J; 2013 Oct; 42(4):893-4. PubMed ID: 24081756
[No Abstract] [Full Text] [Related]
82. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report.
Mogollón MV; Lage E; Cabezón S; Hinojosa R; Ballesteros S; Aranda A; Sobrino JM; Ordóñez A
Transplant Proc; 2006 Oct; 38(8):2522-3. PubMed ID: 17097987
[TBL] [Abstract][Full Text] [Related]
83. Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy.
Hill NS; Preston IR; Roberts KE
Chest; 2008 Aug; 134(2):221-223. PubMed ID: 18682450
[No Abstract] [Full Text] [Related]
84. Severe pulmonary hypertension in histiocytosis X: long-term improvement with bosentan.
Kiakouama L; Cottin V; Etienne-Mastroïanni B; Khouatra C; Humbert M; Cordier JF
Eur Respir J; 2010 Jul; 36(1):202-4. PubMed ID: 20595165
[No Abstract] [Full Text] [Related]
85. An evidence-based approach to the management of pulmonary arterial hypertension.
Coyne TC
Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
[No Abstract] [Full Text] [Related]
86. Disproportionate pulmonary hypertension in a patient with early-onset pulmonary emphysema treated with specific drugs for pulmonary arterial hypertension.
Shimizu M; Imanishi J; Takano T; Miwa Y
Intern Med; 2011; 50(20):2341-6. PubMed ID: 22001462
[TBL] [Abstract][Full Text] [Related]
87. Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.
Minniti CP; Machado RF; Coles WA; Sachdev V; Gladwin MT; Kato GJ
Br J Haematol; 2009 Dec; 147(5):737-43. PubMed ID: 19775299
[TBL] [Abstract][Full Text] [Related]
88. Successful treatment of pulmonary hypertension with beraprost and sildenafil after cord blood transplantation for infantile leukemia.
Kawashima N; Ikoma M; Sekiya Y; Narita A; Yoshida N; Matsumoto K; Hatano T; Kato K
Int J Hematol; 2013 Jan; 97(1):147-50. PubMed ID: 23243005
[TBL] [Abstract][Full Text] [Related]
89. Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis.
Srivastava MC; Ramani GV; Garcia JP; Griffith BP; Uber PA; Park MH
J Heart Lung Transplant; 2010 Jul; 29(7):811-3. PubMed ID: 20417127
[TBL] [Abstract][Full Text] [Related]
90. A new era in the treatment of primary pulmonary hypertension.
Bailey CL; Channick RN; Rubin LJ
Heart; 2001 Mar; 85(3):251-2. PubMed ID: 11179256
[No Abstract] [Full Text] [Related]
91. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
Beghetti M; Galiè N
J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
[TBL] [Abstract][Full Text] [Related]
92. Current pharmacological treatment of pulmonary arterial hypertension.
Steiropoulos P; Trakada G; Bouros D
Curr Clin Pharmacol; 2008 Jan; 3(1):11-9. PubMed ID: 18690874
[TBL] [Abstract][Full Text] [Related]
93. Treatment of rebound pulmonary hypertension: why not sildenafil?
Raja SG
Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
[No Abstract] [Full Text] [Related]
94. Pulmonary arterial hypertension occurrence after liver transplant in systemic sclerosis: a report of 2 cases sustainably treated by sildenafil.
Koumakis E; Wipff J; Kahan A; Allanore Y
Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S53-4. PubMed ID: 20576215
[TBL] [Abstract][Full Text] [Related]
95. Potentiating the pulmonary vasodilatory effects produced by sildenafil.
Dias-Junior CA
Respir Med; 2007 May; 101(5):1041; author reply 1042. PubMed ID: 17321734
[No Abstract] [Full Text] [Related]
96. The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.
Zeng WJ; Lu XL; Xiong CM; Shan GL; Liu ZH; Ni XH; Gu Q; Zhao ZH; Li JJ; He JG;
Clin Cardiol; 2011 Aug; 34(8):513-8. PubMed ID: 21678455
[TBL] [Abstract][Full Text] [Related]
97. Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.
Jue VI
Prog Cardiovasc Nurs; 2004; 19(2):74-9. PubMed ID: 15133384
[No Abstract] [Full Text] [Related]
98. The use of sildenafil to treat portopulmonary hypertension prior to liver transplantation.
Cadden IS; Greanya ED; Erb SR; Scudamore CH; Yoshida EM
Ann Hepatol; 2009; 8(2):158-61. PubMed ID: 19502663
[TBL] [Abstract][Full Text] [Related]
99. Endothelin antagonism in pulmonary arterial hypertension.
Lee SH; Channick RN
Semin Respir Crit Care Med; 2005 Aug; 26(4):402-8. PubMed ID: 16121317
[TBL] [Abstract][Full Text] [Related]
100. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Austin MJ; McDougall NI; Wendon JA; Sizer E; Knisely AS; Rela M; Wilson C; Callender ME; O'Grady JG; Heneghan MA
Liver Transpl; 2008 Mar; 14(3):287-91. PubMed ID: 18306330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
